BioInvent is a research-based pharmaceutical company developing innovative antibody drugs to target diseases with unmet clinical need.

Meet us

7-8 October, Cell Based Assay & Screening Technologies, Dublin, Ireland
29-30 October, AusBiotech 2014, Gold Coast, Australia
3-5 November, BIO Europe 2014, Frankfurt, Germany

Our Pipeline

BioInvent develops antibody-based drugs to tackle conditions where there is a significant need for new treatments. We currently have two antibody therapeutics in development. Find out more »






Press Releases

Latest Share Price

Clinical Trials

BioInvent is currently running early-stage clinical trials with its products. Click here to find out more »








BioInvent International • SE-223 70 Lund, Sweden • Visiting: Sölvegatan 41, Lund, Sweden • Tel: +46 (0)46-286 85 50 • E-mail: info@bioinvent.com